Stocks and Investing
by (remove) : Ying Huang
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Ying Huang
RSSJSONXMLCSV
Fri, July 21, 2023
Fri, January 31, 2020
Wed, November 20, 2019
Thu, October 17, 2019
Thu, February 22, 2018
Thu, February 1, 2018
Fri, January 5, 2018
Wed, October 18, 2017
Fri, September 22, 2017
Mon, July 24, 2017
Wed, February 1, 2017
Mon, July 6, 2015
Tue, July 31, 2012
Wed, March 14, 2012

Ying Huang Maintained (VRTX) at Strong Buy with Increased Target to $400 on, Jul 21st, 2023


Published on 2024-10-28 05:01:02 - WOPRAI, Ying Huang
  Print publication without navigation


Ying Huang of B of A Securities, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $350 to $400 on, Jul 21st, 2023.

Ying has made no other calls on VRTX in the last 4 months.



There are 20 other peers that have a rating on VRTX. Out of the 20 peers that are also analyzing VRTX, 4 agree with Ying's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Reiterated at Hold with Increased Target to $340 on, Friday, June 30th, 2023
  • Brian Abrahams of "RBC Capital" Reiterated at Hold and Held Target at $323 on, Thursday, June 22nd, 2023
  • Brian Skorney of "Baird" Maintained at Hold with Increased Target to $325 on, Tuesday, May 2nd, 2023
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $340 on, Tuesday, May 2nd, 2023


These are the ratings of the 16 analyists that currently disagree with Ying


  • Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $360 on, Wednesday, June 28th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $379 on, Monday, June 26th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $380 on, Monday, June 26th, 2023
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $365 on, Friday, June 23rd, 2023
  • Myles Minter of "William Blair" Initiated at Buy on, Tuesday, May 30th, 2023
  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $385 on, Thursday, May 4th, 2023
  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $400 on, Wednesday, May 3rd, 2023
  • William Pickering of "Bernstein" Maintained at Buy with Increased Target to $363 on, Wednesday, May 3rd, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $399 on, Tuesday, May 2nd, 2023
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $385 on, Tuesday, May 2nd, 2023
  • Evan Seigerman of "BMO Capital" Maintained at Buy and Held Target at $385 on, Tuesday, May 2nd, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $384 on, Tuesday, May 2nd, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $410 on, Tuesday, May 2nd, 2023
  • Jessica Fye of "JP Morgan" Maintained at Buy and Held Target at $345 on, Tuesday, May 2nd, 2023
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $456 on, Tuesday, May 2nd, 2023
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Wednesday, March 29th, 2023
Contributing Sources